Beijing Wantai Biological Pharmacy

Beijing Wantai Biological Pharmacy is one of the...

• CSI 300;
• Forbes Global 2000 (#1741).

Beijing Wantai Biological Pharmacy is a company listed under the stock ticker 603392 (CN).

View the org chart displaying its 1 main executives

Most searched biographies at Beijing Wantai Biological Pharmacy

• Xin Qiu Zi, General Manager & Director

Create your alert
to follow the executive moves at Beijing Wantai Biological Pharmacy.

Beijing Wantai Biological Pharmacy has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Beijing Wantai Biological Pharmacy

Social media about Beijing Wantai Biological Pharmacy

• Beijing Wantai Biological Pharmacy on Wikipedia, Google News & Yahoo Finance
• Beijing Wantai Biological Pharmacy on LinkedIn, Twitter & YouTube

Call Beijing Wantai Biological Pharmacy at +86 105...

View the org chart

Register to receive your alert

Report an error